Please assess the completion status of the following clinical trial:

Trial Title: Comparison of Transdermal and Oral Estrogens in Adolescent Girls With Ovarian Failure

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria: in whom initiation of estrogen therapy has been recommended due to ovarian failure~* Outpatients~* age \>=12 years to 17.99 years old~Exclusion Criteria:~* spontaneous menses~* significant concurrent medical problem including:~* Liver function tests (LFTs) 3 times normal~* clotting disorder~* ongoing cancer treatment

- Gender: FEMALE
- Minimum Age: 12 Years
- Maximum Age: 18 Years
- Healthy Volunteers: f

Study Arms:
- Vivelle-Dot (Type: ACTIVE_COMPARATOR): 17Beta Estradiol - transdermal
- Premarin (Type: ACTIVE_COMPARATOR): Conjugated estrogens
- Estrace (Type: ACTIVE_COMPARATOR): 17beta Estradiol

Based on this trial design, predict the completion outcome and termination type (if applicable).